Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN73,0673,091,25
Msft0,37
Nokia4,5694,638-2,55
IBM0,14
Mercedes-Benz Group AG52,7152,73-0,36
PFE0,17
31.05.2025 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 30.05.2025
IDEXX Labs (IDXX.O, NASDAQ Cons)
Závěr k 30.5.2025 Změna (%) Změna (USD) Objem obchodů (ks)
513,36 -0,42 -2,19 1 221 827
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 01.06.2025
Popis společnosti
Obecné informace
Název společnostiIDEXX Laboratories Inc
TickerIDXX
Kmenové akcie:Ordinary Shares
RICIDXX.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky31.03.2025
Počet zaměstnanců k 31.12.2024 11 000
Akcie v oběhu k 31.03.2025 80 740 000
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
UliceOne Idexx Drive
MěstoWESTBROOK
PSČ04092-2041
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon12 075 560 300
Fax12075564346

Business Summary: IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
Financial Summary: BRIEF: For the three months ended 31 March 2025, IDEXX Laboratories Inc revenues increased 4% to $998.4M. Net income increased 3% to $242.7M. Revenues reflect CAG segment increase of 3% to $1.73B, Water segment increase of 5% to $45.3M, Other segment increase of 32% to $4.7M, United States segment increase of 4% to $654.9M, Asia Pacific segment increase of 7% to $81.7M.
Odvětvová klasifikace
TRBC2012Veterinary Medical Equipment & Supplies
RBSS2004Pharmaceuticals - Generic & Specialty
MGINDUSTRYFish/Livestock
MGSECTORConsumer/Non-Cyclical
NAICSVeterinary Services
NAICSAnalytical Laboratory Instrument Manufacturing
NAICSCustom Computer Programming Services
NAICSIn-Vitro Diagnostic Substance Manufacturing
NAICS2007Veterinary Services
NAICS2007Analytical Laboratory Instrument Mfg
NAICS2007Custom Computer Programming Services
NAICS2007In-Vitro Diagnostic Substance Mfg
NAICS1997Veterinary Services
NAICS1997Analytical Laboratory Instrument Manufacturing
NAICS1997Custom Computer Programming Services
NAICS1997InVitro Diagnostic Substance Manufacturing
SICDiagnostic Substances
SICVeterinary Services, Specialties
SICAnalytical Instruments
SICComputer Programming Services
SICDiagnostic Substances



  • Poslední aktualizace: 01.06.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorJonathan Mazelsky6423.10.2019
Executive Vice President, Chief Executive Officer, TreasurerAndrew Emerson4201.03.202501.03.2025
Chief Financial Officer, Executive Vice President, TreasurerBrian Mckeon6301.01.201401.01.2014
Chief Human Resources Officer, Executive Vice PresidentMichael Johnson48
Executive Vice President, General Counsel, Corporate SecretarySharon Underberg6331.12.202101.03.2019
Executive Vice President and General Manager, Point of Care Diagnostics and TelemedicineMichael Erickson51
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information TechnologyMichael Lane5701.01.2025
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer ExperienceMichael Schreck57
Executive Vice President - Global CAG CommercialGeorge Fennell56
Executive Vice President - Global Strategy and CommercialTina Hunt5701.01.2025